- Home
- RUN vs CPRX Comparison
RUN vs CPRX Comparison
Compare RUN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUN
- CPRX
- Stock Information
- Founded
- RUN 2007
- CPRX 2002
- Country
- RUN United States
- CPRX United States
- Employees
- RUN N/A
- CPRX N/A
- Industry
- RUN Industrial Machinery/Components
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- RUN Miscellaneous
- CPRX Health Care
- Exchange
- RUN Nasdaq
- CPRX Nasdaq
- Market Cap
- RUN 2.3B
- CPRX 2.5B
- IPO Year
- RUN 2015
- CPRX 2006
- Fundamental
- Price
- RUN $9.87
- CPRX $21.27
- Analyst Decision
- RUN Buy
- CPRX Strong Buy
- Analyst Count
- RUN 22
- CPRX 7
- Target Price
- RUN $19.81
- CPRX $31.14
- AVG Volume (30 Days)
- RUN 8.2M
- CPRX 916.5K
- Earning Date
- RUN 02-19-2025
- CPRX 11-06-2024
- Dividend Yield
- RUN N/A
- CPRX N/A
- EPS Growth
- RUN N/A
- CPRX 114.68
- EPS
- RUN N/A
- CPRX 1.18
- Revenue
- RUN $2,035,817,000.00
- CPRX $460,482,000.00
- Revenue This Year
- RUN N/A
- CPRX $23.98
- Revenue Next Year
- RUN $13.94
- CPRX $18.27
- P/E Ratio
- RUN N/A
- CPRX $18.05
- Revenue Growth
- RUN N/A
- CPRX 32.17
- 52 Week Low
- RUN $9.01
- CPRX $13.12
- 52 Week High
- RUN $22.26
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- RUN 40.92
- CPRX 45.60
- Support Level
- RUN $9.86
- CPRX $20.93
- Resistance Level
- RUN $10.58
- CPRX $22.67
- Average True Range (ATR)
- RUN 0.68
- CPRX 0.66
- MACD
- RUN 0.00
- CPRX -0.07
- Stochastic Oscillator
- RUN 31.50
- CPRX 19.54
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed either by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.